You are here

Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol.

Pubmed ID: 
29574444
Year: 
2018
Month: 
03
Volume: 
8
Issue: 
3
Citation: 
Peacock A, Larance B, Farrell M, Cairns R, Buckley N, Degenhardt L. Opioid use and harms associated with a sustained-release tapentadol formulation: a postmarketing study protocol. BMJ Open 8 (3) : e020006(2018) PubMed (Grant IDs: 1073858, 1109366, 1041472)